Mitesco’s (MITI) CEO Featured In Yahoo News Video.

Michael C. Howe, CEO of Mitesco's 'Good Clinic' and Original Partner of CVS the Acquired 'Minute Clinic' on Yahoo's Finance Channel....

Good Clinic Owned by Mitesco (MITI) In Star Tribune.

Former MinuteClinic Principals Open Walk-in Clinic in Minneapolis, Plan 3 More This Year. 50 Clinics Planned in Next Three Years.
Draganfly, Drone Stock Review

Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.

Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a...

Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy

VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...
Drone Stock Review, Cameron Chell

Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

Closes $20 Million Raise.Uplists to NASDAQ.Pilot Training for First Responders Firefighters, Search and Rescue Commences.Reports Record Revenues for Second Quarter.Shareholder Update and...
Biotech Stock Review, DYAI

Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).

Share Price up 27% ($4.63 up $1.04) as Wall Street Sorts out the Terms of the Deal. We've had...
Drone Stock Review. Draganfly

Draganfly (DPRO) Shareholder Call Today, 4PM EST.

https://youtu.be/SwKfEfKi8rU Shareholder update call today August 12, 2021 at 2PM MST / 4PM EST.
ehave,

Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

Contactless Health Screening Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...
Biotech Stock Review

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.

Added to Watch List November 2019 @$0.55. Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...

Alkaline Water Co., (WTER) Announces 33rd Straight Up Quarter.

"This quarter also saw record revenue and strong continued growth. Even when compared to last year’s pantry-loading, our first quarter fiscal 2022...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!